Dr. Reddy's Laboratories launches Regadenoson Injection 0.4mg/5mL in US market https://ift.tt/meIcNo0

The injection is the generic therapeutic equivalent of the US Food and Drug Administration (US FDA)-approved Lexiscan (Regadenoson) injection. To test the heart for coronary artery disease, the injection is utilised.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/ZPhXGVw
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.